Title:
ANTI-ARRHYTHMIC PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2021/196982
Kind Code:
A1
Abstract:
Disclosed is an anti-arrhythmic pharmaceutical composition, characterized in that the pharmaceutical composition comprises an active ingredient, 1-(3-methanesulfonamido benzyl)-6-methoxy, 7-benzyloxy-1,2,3,4-tetrahydroisoquinoline or a pharmaceutically acceptable salt thereof; and auxiliary materials, lactose, microcrystalline cellulose and a pre-gelatinised starch, which account for 30％ to 80％ of the total weight of the composition. The composition has a good dissolution effect and stability, and can be better used in clinical applications.
Inventors:
XIAO WEI (CN)
ZHANG HUI (CN)
GUO QINGMING (CN)
WANG ZHENZHONG (CN)
ZHANG HUI (CN)
GUO QINGMING (CN)
WANG ZHENZHONG (CN)
Application Number:
PCT/CN2021/079508
Publication Date:
October 07, 2021
Filing Date:
March 08, 2021
Export Citation:
Assignee:
JIANGSU KANION PHARMACEUTICAL CO LTD (CN)
International Classes:
A61K31/472; A61K9/20; A61P9/06
Foreign References:
| CN1566098A | 2005-01-19 | |||
| CN105362245A | 2016-03-02 | |||
| CN104693115A | 2015-06-10 | |||
| US20190177277A1 | 2019-06-13 | |||
| CN200710181295A | 2003-07-02 |
Other References:
PENG, SIXUN ET AL.: "Cardiovascular Drug Research: Structural Modification Based on Active Components from Traditional Chinese Medicine", JOURNAL OF CHINA PHARMACEUTICAL UNIVERSITY, vol. 30, no. 5, 31 December 1999 (1999-12-31), pages 396 - 400, XP055854536
Attorney, Agent or Firm:
BEIJING LAWSING IP FIRM (CN)
Download PDF:
Previous Patent: VOICE INTERACTION METHOD AND APPARATUS, AND TERMINAL DEVICE
Next Patent: EGO-MOTION ESTIMATION METHOD AND APPARATUS
Next Patent: EGO-MOTION ESTIMATION METHOD AND APPARATUS